Financials

News Ideas Technicals

IZO fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Izotropic Corp. engages in the development and commercialization of IzoView, a CT imaging device with a platform of targeted uses. Its initial plan was to complete the engineering of the first imaging device and seek approval in the USA as a diagnostic device for detecting breast cancers. The company was founded by John M. Boone and Robert Louis Thast on May 19, 2016 and is headquartered in Surrey, Canada.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

IZO does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company